SPATA31D3 (SPATA31 subfamily D member 3) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: SPATA31D3 (SPATA31 subfamily D member 3) Homo sapiens
Analyze
Symbol: SPATA31D3
Name: SPATA31 subfamily D member 3
RGD ID: 4140036
HGNC Page HGNC:38603
Description: Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in membrane.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: FAM75-like protein FLJ44082; FAM75D3; family with sequence similarity 75, member D3; FLJ44082; hypothetical protein LOC389762; Putative FAM75-like protein FLJ44082; putative protein FAM75D3; putative spermatogenesis-associated protein 31D3; SPATA31 subfamily D, member 3; spermatogenesis-associated protein 31D3
RGD Orthologs
Rat
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38981,943,500 - 81,950,093 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl981,943,500 - 81,950,093 (+)EnsemblGRCh38hg38GRCh38
GRCh37984,558,415 - 84,565,008 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36983,748,235 - 83,754,829 (+)NCBINCBI36Build 36hg18NCBI36
Cytogenetic Map9q21.32NCBI
CHM1_1984,705,025 - 84,711,496 (+)NCBICHM1_1
T2T-CHM13v2.0994,093,143 - 94,099,738 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process

Cellular Component
membrane  (IEA)

References

References - curated
# Reference Title Reference Citation
1. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:14702039   PMID:15164053   PMID:33961781   PMID:37704626  


Genomics

Comparative Map Data
SPATA31D3
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38981,943,500 - 81,950,093 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl981,943,500 - 81,950,093 (+)EnsemblGRCh38hg38GRCh38
GRCh37984,558,415 - 84,565,008 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36983,748,235 - 83,754,829 (+)NCBINCBI36Build 36hg18NCBI36
Cytogenetic Map9q21.32NCBI
CHM1_1984,705,025 - 84,711,496 (+)NCBICHM1_1
T2T-CHM13v2.0994,093,143 - 94,099,738 (+)NCBIT2T-CHM13v2.0
Spata31d3
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr8174,965,751 - 4,976,723 (+)NCBIGRCr8
mRatBN7.2174,964,815 - 4,971,203 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl174,964,834 - 4,971,015 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx174,984,796 - 4,991,232 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0176,526,527 - 6,564,641 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0174,981,241 - 4,987,677 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0175,342,820 - 5,348,844 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl175,342,829 - 5,348,813 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0177,567,498 - 7,573,821 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41710,870,405 - 10,876,329 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11710,870,404 - 10,938,942 (+)NCBI
Celera175,085,782 - 5,091,890 (+)NCBICelera
Cytogenetic Map17p14NCBI

Variants

.
Variants in SPATA31D3
21 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh37/hg19 9q21.11-34.3(chr9:71069743-140999928) copy number gain Global developmental delay [RCV000626548] Chr9:71069743..140999928 [GRCh37]
Chr9:9q21.11-34.3
likely pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 copy number gain See cases [RCV000050348] Chr9:193412..138179445 [GRCh38]
Chr9:204193..141073897 [GRCh37]
Chr9:194193..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9q21.31-21.32(chr9:81051602-82804697)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052232]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052232]|See cases [RCV000052232] Chr9:81051602..82804697 [GRCh38]
Chr9:83666517..85419612 [GRCh37]
Chr9:82856337..84609432 [NCBI36]
Chr9:9q21.31-21.32
uncertain significance
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124532)x3 copy number gain See cases [RCV000053745] Chr9:193412..138124532 [GRCh38]
Chr9:204193..141018984 [GRCh37]
Chr9:194193..140138805 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138114463)x3 copy number gain See cases [RCV000053746] Chr9:193412..138114463 [GRCh38]
Chr9:214367..141008915 [GRCh37]
Chr9:204367..140128736 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|See cases [RCV000053748] Chr9:193412..138179445 [GRCh38]
Chr9:266045..141073897 [GRCh37]
Chr9:256045..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:204193-138179445) copy number gain See cases [RCV000133791] Chr9:204193..138179445 [GRCh38]
Chr9:204193..141073897 [GRCh37]
Chr9:194193..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9q21.11-31.2(chr9:68420430-106579493)x3 copy number gain See cases [RCV000136788] Chr9:68420430..106579493 [GRCh38]
Chr9:71130848..109341774 [GRCh37]
Chr9:70225166..108381595 [NCBI36]
Chr9:9q21.11-31.2
pathogenic
GRCh38/hg38 9q21.11-21.32(chr9:68499530-83670227)x1 copy number loss See cases [RCV000137963] Chr9:68499530..83670227 [GRCh38]
Chr9:71130848..86285142 [GRCh37]
Chr9:70304266..85474962 [NCBI36]
Chr9:9q21.11-21.32
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124524)x3 copy number gain See cases [RCV000138783] Chr9:193412..138124524 [GRCh38]
Chr9:204090..141018976 [GRCh37]
Chr9:194090..140138797 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p11.2-q34.3(chr9:193412-138159073)x3 copy number gain See cases [RCV000139207] Chr9:193412..138159073 [GRCh38]
Chr9:68420641..141053525 [GRCh37]
Chr9:67910461..140173346 [NCBI36]
Chr9:9p11.2-q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138159073)x3 copy number gain See cases [RCV000138962] Chr9:193412..138159073 [GRCh38]
Chr9:204104..141053525 [GRCh37]
Chr9:194104..140173346 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic|conflicting data from submitters
GRCh38/hg38 9q21.12-31.3(chr9:69627642-111454304)x3 copy number gain See cases [RCV000139789] Chr9:69627642..111454304 [GRCh38]
Chr9:72242558..114216584 [GRCh37]
Chr9:71432378..113256405 [NCBI36]
Chr9:9q21.12-31.3
pathogenic
GRCh38/hg38 9p24.3-q22.1(chr9:203861-88130444)x4 copy number gain See cases [RCV000141904] Chr9:203861..88130444 [GRCh38]
Chr9:203861..90745359 [GRCh37]
Chr9:193861..89935179 [NCBI36]
Chr9:9p24.3-q22.1
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:203861-138125937)x3 copy number gain See cases [RCV000141876] Chr9:203861..138125937 [GRCh38]
Chr9:203861..141020389 [GRCh37]
Chr9:193861..140140210 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:203862-138125937)x3 copy number gain See cases [RCV000143476] Chr9:203862..138125937 [GRCh38]
Chr9:203862..141020389 [GRCh37]
Chr9:193862..140140210 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 copy number gain See cases [RCV000148113] Chr9:193412..138179445 [GRCh38]
Chr9:204193..141073897 [GRCh37]
Chr9:194193..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:163131-141122114)x3 copy number gain See cases [RCV000240081] Chr9:163131..141122114 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:62525-141006407) copy number gain See cases [RCV000449375] Chr9:62525..141006407 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020389)x3 copy number gain not specified [RCV003986800] Chr9:203861..141020389 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:203864-141020389)x3 copy number gain See cases [RCV000448978] Chr9:203864..141020389 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
NM_207416.3(SPATA31D3):c.2306A>T (p.Tyr769Phe) single nucleotide variant Inborn genetic diseases [RCV003294926] Chr9:81947559 [GRCh38]
Chr9:84562474 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2731C>A (p.Pro911Thr) single nucleotide variant Inborn genetic diseases [RCV003311061] Chr9:81947984 [GRCh38]
Chr9:84562899 [GRCh37]
Chr9:9q21.32
uncertain significance
GRCh37/hg19 9q21.11-22.1(chr9:70966262-90761254)x4 copy number gain See cases [RCV000512280] Chr9:70966262..90761254 [GRCh37]
Chr9:9q21.11-22.1
pathogenic
GRCh37/hg19 9p24.3-q21.33(chr9:203861-88189913)x3 copy number gain See cases [RCV000512431] Chr9:203861..88189913 [GRCh37]
Chr9:9p24.3-q21.33
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:203862-141020389) copy number gain See cases [RCV000512392] Chr9:203862..141020389 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9q21.11-21.32(chr9:68999534-84656998)x1 copy number loss not provided [RCV000683169] Chr9:68999534..84656998 [GRCh37]
Chr9:9q21.11-21.32
pathogenic
Single allele complex Glioma [RCV000754871] Chr9:23524426..87359888 [GRCh37]
Chr9:9p21.3-q21.33
likely pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141122247)x3 copy number gain not provided [RCV000748055] Chr9:10590..141122247 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9q21.31-21.32(chr9:83643410-85495968)x3 copy number gain not provided [RCV000748492] Chr9:83643410..85495968 [GRCh37]
Chr9:9q21.31-21.32
uncertain significance
GRCh37/hg19 9q21.32(chr9:84530066-84564110)x1 copy number loss not provided [RCV000748496] Chr9:84530066..84564110 [GRCh37]
Chr9:9q21.32
benign
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141107672)x3 copy number gain not provided [RCV000748053] Chr9:10590..141107672 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:46587-141066491)x3 copy number gain not provided [RCV000748063] Chr9:46587..141066491 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141114095)x2 copy number gain not provided [RCV000748054] Chr9:10590..141114095 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9q21.2-22.32(chr9:79520825-97201274) copy number gain not provided [RCV000767645] Chr9:79520825..97201274 [GRCh37]
Chr9:9q21.2-22.32
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020388)x3 copy number gain not provided [RCV000845900] Chr9:203861..141020388 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9q21.11-34.3(chr9:71416475-141020389)x3 copy number gain not provided [RCV000847808] Chr9:71416475..141020389 [GRCh37]
Chr9:9q21.11-34.3
pathogenic
NM_207416.3(SPATA31D3):c.2582C>T (p.Pro861Leu) single nucleotide variant Inborn genetic diseases [RCV003273683] Chr9:81947835 [GRCh38]
Chr9:84562750 [GRCh37]
Chr9:9q21.32
uncertain significance
NC_000009.11:g.12246100_101559378inv inversion Recurrent spontaneous abortion [RCV000999471] Chr9:12246100..101559378 [GRCh37]
Chr9:9p23-q22.33
likely pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:353349-141020389) copy number gain not specified [RCV002053823] Chr9:353349..141020389 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9q21.11-33.2(chr9:71349994-122603410) copy number gain not specified [RCV002053853] Chr9:71349994..122603410 [GRCh37]
Chr9:9q21.11-33.2
likely pathogenic
GRCh37/hg19 9p24.3-q34.11(chr9:203861-131603223)x3 copy number gain See cases [RCV002292402] Chr9:203861..131603223 [GRCh37]
Chr9:9p24.3-q34.11
pathogenic
GRCh37/hg19 9p22.1-q33.1(chr9:19356861-119513311) copy number loss Distal tetrasomy 15q [RCV002280776] Chr9:19356861..119513311 [GRCh37]
Chr9:9p22.1-q33.1
uncertain significance
NM_207416.3(SPATA31D3):c.2659C>A (p.Gln887Lys) single nucleotide variant Inborn genetic diseases [RCV002907199] Chr9:81947912 [GRCh38]
Chr9:84562827 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2180G>A (p.Gly727Asp) single nucleotide variant Inborn genetic diseases [RCV002688611] Chr9:81947433 [GRCh38]
Chr9:84562348 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2330C>T (p.Ala777Val) single nucleotide variant Inborn genetic diseases [RCV002864830] Chr9:81947583 [GRCh38]
Chr9:84562498 [GRCh37]
Chr9:9q21.32
uncertain significance
GRCh37/hg19 9q21.31-21.32(chr9:84027223-84848369)x3 copy number gain not provided [RCV002475691] Chr9:84027223..84848369 [GRCh37]
Chr9:9q21.31-21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2083C>T (p.Arg695Cys) single nucleotide variant Inborn genetic diseases [RCV002661165] Chr9:81947336 [GRCh38]
Chr9:84562251 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2373G>T (p.Glu791Asp) single nucleotide variant Inborn genetic diseases [RCV002713567] Chr9:81947626 [GRCh38]
Chr9:84562541 [GRCh37]
Chr9:9q21.32
likely benign
NM_207416.3(SPATA31D3):c.2373G>C (p.Glu791Asp) single nucleotide variant Inborn genetic diseases [RCV002789886] Chr9:81947626 [GRCh38]
Chr9:84562541 [GRCh37]
Chr9:9q21.32
likely benign
NM_207416.3(SPATA31D3):c.2179G>A (p.Gly727Ser) single nucleotide variant Inborn genetic diseases [RCV002929510] Chr9:81947432 [GRCh38]
Chr9:84562347 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2180G>T (p.Gly727Val) single nucleotide variant Inborn genetic diseases [RCV002929511] Chr9:81947433 [GRCh38]
Chr9:84562348 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2434A>G (p.Asn812Asp) single nucleotide variant Inborn genetic diseases [RCV002807625] Chr9:81947687 [GRCh38]
Chr9:84562602 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.255A>C (p.Glu85Asp) single nucleotide variant Inborn genetic diseases [RCV002835828] Chr9:81945194 [GRCh38]
Chr9:84560109 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2365T>A (p.Ser789Thr) single nucleotide variant Inborn genetic diseases [RCV002934737] Chr9:81947618 [GRCh38]
Chr9:84562533 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2428T>C (p.Ser810Pro) single nucleotide variant Inborn genetic diseases [RCV002792497] Chr9:81947681 [GRCh38]
Chr9:84562596 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2574A>G (p.Ile858Met) single nucleotide variant Inborn genetic diseases [RCV002652905] Chr9:81947827 [GRCh38]
Chr9:84562742 [GRCh37]
Chr9:9q21.32
likely benign
NM_207416.3(SPATA31D3):c.2576G>C (p.Cys859Ser) single nucleotide variant Inborn genetic diseases [RCV002652906] Chr9:81947829 [GRCh38]
Chr9:84562744 [GRCh37]
Chr9:9q21.32
likely benign
NM_207416.3(SPATA31D3):c.2488C>T (p.His830Tyr) single nucleotide variant Inborn genetic diseases [RCV002679823] Chr9:81947741 [GRCh38]
Chr9:84562656 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2391C>G (p.Asn797Lys) single nucleotide variant Inborn genetic diseases [RCV003201352] Chr9:81947644 [GRCh38]
Chr9:84562559 [GRCh37]
Chr9:9q21.32
uncertain significance
NM_207416.3(SPATA31D3):c.2581C>T (p.Pro861Ser) single nucleotide variant Inborn genetic diseases [RCV003207507] Chr9:81947834 [GRCh38]
Chr9:84562749 [GRCh37]
Chr9:9q21.32
likely benign
NM_207416.3(SPATA31D3):c.275T>C (p.Leu92Pro) single nucleotide variant Inborn genetic diseases [RCV003265040] Chr9:81945214 [GRCh38]
Chr9:84560129 [GRCh37]
Chr9:9q21.32
uncertain significance
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:201
Count of miRNA genes:155
Interacting mature miRNAs:159
Transcripts:ENST00000334208, ENST00000445385
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region
CHLC.GAAT4F02  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37984,559,290 - 84,559,559UniSTSGRCh37
GRCh37984,544,218 - 84,544,487UniSTSGRCh37
Build 36983,734,038 - 83,734,307RGDNCBI36
Cytogenetic Map9q21.32UniSTS
Whitehead-YAC Contig Map9 UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage
High
Medium 63
Low 1 1 301
Below cutoff 97 104 54 14 40 8 137 91 108 8 70 51 6 47 88

Sequence


RefSeq Acc Id: ENST00000445385   ⟹   ENSP00000488117
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl981,943,500 - 81,950,093 (+)Ensembl
RefSeq Acc Id: NM_207416   ⟹   NP_997299
RefSeq Status: VALIDATED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38981,943,500 - 81,950,093 (+)NCBI
GRCh37984,558,415 - 84,565,009 (+)RGD
T2T-CHM13v2.0994,093,143 - 94,099,738 (+)NCBI
Sequence:
Protein Sequences
Protein RefSeqs NP_997299 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein CCQ43955 (Get FASTA)   NCBI Sequence Viewer  
Ensembl Protein ENSP00000488117
  ENSP00000488117.1
GenBank Protein P0C874 (Get FASTA)   NCBI Sequence Viewer  
RefSeq Acc Id: NP_997299   ⟸   NM_207416
- UniProtKB: P0C874 (UniProtKB/Swiss-Prot)
- Sequence:
RefSeq Acc Id: ENSP00000488117   ⟸   ENST00000445385

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P0C874-F1-model_v2 AlphaFold P0C874 1-917 view protein structure


Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:38603 AgrOrtholog
COSMIC SPATA31D3 COSMIC
Ensembl Genes ENSG00000186788 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENST00000445385 ENTREZGENE
  ENST00000445385.3 UniProtKB/Swiss-Prot
GTEx ENSG00000186788 GTEx
HGNC ID HGNC:38603 ENTREZGENE
Human Proteome Map SPATA31D3 Human Proteome Map
InterPro DUF4599 UniProtKB/Swiss-Prot
  SPATA31/FAM205 UniProtKB/Swiss-Prot
KEGG Report hsa:389762 UniProtKB/Swiss-Prot
NCBI Gene 389762 ENTREZGENE
PANTHER ACROSOME-SPECIFIC PROTEIN UniProtKB/Swiss-Prot
  SPERMATOGENESIS-ASSOCIATED PROTEIN 31D3-RELATED UniProtKB/Swiss-Prot
Pfam DUF4599 UniProtKB/Swiss-Prot
  FAM75 UniProtKB/Swiss-Prot
PharmGKB PA166049032 PharmGKB
UniProt P0C874 ENTREZGENE, UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-06-14 SPATA31D3  SPATA31 subfamily D member 3    SPATA31 subfamily D, member 3  Symbol and/or name change 5135510 APPROVED
2012-10-16 SPATA31D3  SPATA31 subfamily D, member 3  FAM75D3  family with sequence similarity 75, member D3  Symbol and/or name change 5135510 APPROVED